Fortress Biotech

FBIO NASDAQ
1.640
-0.070
-4.09%
盘后: 1.640 0 0.00% 17:55 06/24 EDT
开盘
1.720
昨收
1.710
最高
1.740
最低
1.600
成交量
55.42万
成交均量(3M)
71.76万
52周最高
3.379
52周最低
0.4900
换手率
0.85%
市值
1.07亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Fortress Biotech FBIO股票价格,Fortress Biotech股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
展开 >

最近浏览

名称
价格
涨跌幅